Metformin is the key factor in elevated plasma growth differentiation factor ‐15 levels in type 2 diabetes: A nested, case–control study
Diabetes, Obesity and Metabolism, EarlyView.
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Andrea Natali,
Lorenzo Nesti,
Elena Venturi,
Angela C. Shore,
Faisel Khan,
Kim Gooding,
Phillip E. Gates,
Helen C. Looker,
Fiona Dove,
Isabel Goncalves,
Margaretha Persson,
Jan Nilsson,
on behalf of the SUMMIT consortium Source Type: research
More News: Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Fortamet | Metformin | Obesity | Study